BNP PARIBAS FINANCIAL MARKETS - VTV THERAPEUTICS INC ownership

VTV THERAPEUTICS INC's ticker is VTVT and the CUSIP is 918385105. A total of 24 filers reported holding VTV THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of VTV THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$157
-35.4%
3290.0%0.00%
Q2 2023$243
-8.6%
3290.0%0.00%
Q1 2023$266
+21.5%
329
-0.3%
0.00%
Q4 2022$219
-99.9%
3300.0%0.00%
Q3 2022$320,000
+29.0%
3300.0%0.00%
Q2 2022$248,000
+4.2%
3300.0%0.00%
Q1 2022$238,000
-70.0%
330
-58.6%
0.00%
Q4 2021$793,000
-42.8%
797
-12.0%
0.00%
Q3 2021$1,386,000
-38.2%
906
-7.9%
0.00%
Q2 2021$2,244,000
-33.7%
984
-18.0%
0.00%
Q1 2021$3,384,000
+36.8%
1,200
-9.8%
0.00%
Q4 2020$2,474,000
-38.5%
1,330
-41.5%
0.00%
Q3 2020$4,025,000
+387.3%
2,274
+519.6%
0.00%
Q2 2020$826,000
+13666.7%
367
+12133.3%
0.00%
Q1 2020$6,000
+20.0%
30.0%0.00%
Q4 2019$5,000
-70.6%
3
-72.7%
0.00%
Q3 2019$17,000
+6.2%
110.0%0.00%
Q2 2019$16,000
-15.8%
110.0%0.00%
Q1 2019$19,000
-34.5%
110.0%0.00%
Q4 2018$29,000
+262.5%
110.0%0.00%
Q3 2018$8,000
-52.9%
110.0%0.00%
Q2 2018$17,000
-99.7%
11
-99.3%
0.00%
Q1 2018$6,219,000
-40.4%
1,528
-11.9%
0.00%
Q4 2017$10,427,000
+95.7%
1,735
+94.7%
0.00%
Q3 2017$5,328,000
+13.6%
891
-5.6%
0.00%
Q2 2017$4,692,000
+356.4%
944
+501.3%
0.00%
Q1 2017$1,028,000
-59.4%
157
-70.0%
0.00%
Q4 2016$2,531,000
-41.7%
524
-13.2%
0.00%
Q3 2016$4,343,000
+93.5%
604
+56.1%
0.00%
Q2 2016$2,245,000
-69.5%
387
-64.2%
0.00%
Q4 2015$7,368,000
-0.9%
1,082
-5.1%
0.00%
Q3 2015$7,433,0001,1400.00%
Other shareholders
VTV THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CIM INVESTMENT MANAGEMENT INC 177,373$404,0000.12%
Winthrop Advisory Group LLC 3,024$416,0000.09%
Game Plan Financial Advisors, LLC 13,000$30,0000.02%
XTX Topco Ltd 20,045$46,0000.02%
CITIZENS FINANCIAL GROUP INC/RI 70,000$160,0000.01%
HRT FINANCIAL LP 243,250$554,0000.01%
Engineers Gate Manager LP 25,255$58,0000.00%
MARSHALL WACE, LLP 272,255$621,0000.00%
Ergoteles LLC 54,200$124,0000.00%
Tower Research Capital LLC (TRC) 38,821$89,0000.00%
View complete list of VTV THERAPEUTICS INC shareholders